Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
12.29
-1.31 (-9.60%)
At close: Apr 1, 2025, 4:00 PM
12.21
-0.08 (-0.65%)
After-hours: Apr 1, 2025, 7:23 PM EDT

Denali Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,7852,9332,9663,7775,44710,044
Upgrade
Market Cap Growth
-1.10%-1.10%-21.48%-30.66%-45.77%500.43%
Upgrade
Enterprise Value
6471,7041,9022,7334,1539,133
Upgrade
Last Close Price
12.2920.3821.4627.8144.6083.76
Upgrade
PE Ratio
-----141.20
Upgrade
PS Ratio
-8.9734.82111.9329.92
Upgrade
PB Ratio
1.442.382.883.625.668.73
Upgrade
P/TBV Ratio
2.382.382.883.625.668.73
Upgrade
P/FCF Ratio
----24.32
Upgrade
P/OCF Ratio
----24.14
Upgrade
EV/Sales Ratio
-5.7625.2085.3527.21
Upgrade
EV/EBITDA Ratio
----128.18
Upgrade
EV/EBIT Ratio
----145.62
Upgrade
EV/FCF Ratio
----22.11
Upgrade
Debt / Equity Ratio
0.040.040.050.060.070.06
Upgrade
Debt / EBITDA Ratio
-----0.87
Upgrade
Debt / FCF Ratio
-----0.17
Upgrade
Asset Turnover
--0.250.080.030.31
Upgrade
Quick Ratio
8.168.1613.313.702.2920.58
Upgrade
Current Ratio
8.468.4613.653.772.3720.86
Upgrade
Return on Equity (ROE)
-37.40%-37.40%-14.01%-32.52%-27.51%9.21%
Upgrade
Return on Assets (ROA)
-24.82%-24.82%-9.40%-14.87%-12.29%3.63%
Upgrade
Return on Capital (ROIC)
-26.50%-26.50%-11.25%-20.00%-16.46%4.65%
Upgrade
Return on Capital Employed (ROCE)
-----4.10%
Upgrade
Earnings Yield
-23.69%-14.41%-4.90%-8.63%-5.33%0.71%
Upgrade
FCF Yield
-20.37%-12.40%-12.51%-6.95%-4.04%4.11%
Upgrade
Buyback Yield / Dilution
-19.73%-19.73%-9.43%-3.30%-7.83%-17.88%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q